- Home
- Publications
- Publication Search
- Publication Details
Title
Potentiating cancer vaccine efficacy in liver cancer
Authors
Keywords
-
Journal
OncoImmunology
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2018-07-24
DOI
10.1080/2162402x.2018.1488564
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer vaccine: learning lessons from immune checkpoint inhibitors
- (2018) ZhenLong Ye et al. Journal of Cancer
- Long-lasting Response with Metronomic Capecitabine in Advanced Hepatocellular Carcinoma
- (2018) Pierluigi Ballardini et al. TUMORI
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
- (2017) Giovanni Germano et al. NATURE
- Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
- (2017) Annacarmen Petrizzo et al. Oncotarget
- Combinatorial immunotherapy strategies for hepatocellular carcinoma
- (2016) Maria Tagliamonte et al. CURRENT OPINION IN IMMUNOLOGY
- Rationale and design of the DP-TRANSFERS project: diabetes prevention-transferring findings from European research to society in Catalonia
- (2016) Bernardo Costa et al. Journal of Translational Medicine
- The Human Vaccines Project: A roadmap for cancer vaccine development
- (2016) Pedro Romero et al. Science Translational Medicine
- Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
- (2016) Eileen S. Kim et al. Journal of Immunology Research
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
- (2015) Maria Tagliamonte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Developments in cancer vaccines for hepatocellular carcinoma
- (2015) Luigi Buonaguro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?
- (2015) Antonio Gnoni et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication
- (2015) O. A. Ali et al. Cancer Immunology Research
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence-based comparison and review
- (2014) Zhi Ven Fong et al. CANCER
- Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody
- (2014) L. Karyampudi et al. CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled Trial
- (2014) Chunfeng Qu et al. PLOS MEDICINE
- Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
- (2014) A. C. Anderson Cancer Immunology Research
- Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
- (2013) C. J. Nirschl et al. CLINICAL CANCER RESEARCH
- Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model
- (2013) A. Morales-Kastresana et al. CLINICAL CANCER RESEARCH
- Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases
- (2013) Sara Marinelli et al. Hepatitis Monthly
- Human CD14+CTLA-4+regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma
- (2013) Yanmei Han et al. HEPATOLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Challenges in cancer vaccine development for hepatocellular carcinoma
- (2013) Luigi Buonaguro et al. JOURNAL OF HEPATOLOGY
- Dual role of immunomodulation by anticancer chemotherapy
- (2013) Michael R Shurin NATURE MEDICINE
- Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study
- (2013) G. Brandi et al. ONCOLOGIST
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
- (2012) Yu-Yun Shao et al. ONCOLOGY
- Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
- (2011) Yingzi Ge et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma
- (2011) Eishiro Mizukoshi et al. HEPATOLOGY
- Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program
- (2011) Brian J. McMahon et al. HEPATOLOGY
- Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
- (2011) Chao-Yu Hsu et al. JOURNAL OF HEPATOLOGY
- Cancer Cells Containing Nanoscale Chemotherapeutic Drugs Generate Antiovarian Cancer-specific CD4+ T Cells in Peritoneal Space
- (2011) Jee-Eun Kim et al. JOURNAL OF IMMUNOTHERAPY
- PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
- (2010) Feng Shi et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma
- (2010) Chih-Hung Hsu et al. JOURNAL OF HEPATOLOGY
- Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC
- (2010) Tim F. Greten et al. JOURNAL OF IMMUNOTHERAPY
- Cancer/testis (CT) antigens: Potential targets for immunotherapy
- (2009) Otavia L. Caballero et al. CANCER SCIENCE
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
- Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
- (2009) Mei-Hwei Chang et al. JNCI-Journal of the National Cancer Institute
- Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status
- (2009) Nitin Saini et al. LIVER INTERNATIONAL
- Platinum neurotoxicity pharmacogenetics
- (2009) S. R. McWhinney et al. MOLECULAR CANCER THERAPEUTICS
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement
- (2008) C. T. Garnett et al. CLINICAL CANCER RESEARCH
- Allogeneic Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
- (2008) D. Laheru et al. CLINICAL CANCER RESEARCH
- Impact of different anticancer regimens on biomarkers of angiogenesis in patients with advanced hepatocellular cancer
- (2008) G. Treiber et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now